SEATTLE, July 15, 2019 /PRNewswire/ -- Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, neuroscience and biodefense, announced today that it has secured a grant from the National Institute of Allergy and Infectious Diseases (NIAID) worth up to $5.8 million over 5 years

NEW YORK, July 15, 2019 /PRNewswire/ -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the July 11th life sciences conference are now available for on-demand viewing at VirtualInvestorConferences.com.

TORONTO, July 15, 2019 /PRNewswire/ - (PLYZ:OTCQB)- Plyzer Technologies, Inc ("PLYZER" or "THE COMPANY") is pleased to announce that Laboratorios Viñas (

SUMMIT, N.J., July 15, 2019 /PRNewswire/ --Seqirus is first to begin shipping its portfolio of seasonal influenza vaccines for the upcoming 2019/20 U.S. influenza season Seqirus plans to distribute more than 50 million doses of influenza vaccines to healthcare providers across the U.S. throughout the immunization season The Seqir

NEW YORK, July 15, 2019 /PRNewswire/ -- Neurotrope Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzh

SAN DIEGO, July 15, 2019 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ company, developing targeted therapies to treat cancers with significant medical need for new treatment options, is pleased to release to shareholders and investors its latest Company Presentation ahead of commencing a roadshow to i

BRIDGEWATER, N.J., July 15, 2019 /PRNewswire/ -- No matter the time of year, most would welcome the opportunity to get away to an all-encompassing resort. Now, with the opening of Life Tim

VANCOUVER, July 15, 2019 /PRNewswire/ - Harvest One Cannabis Inc. ("Harvest One" or the Company") (TSX-V: HVT; OTCQX: HRVOF) is pleased to announce its wholly-owned subsidiary United Greeneries Ltd. ("United Greeneries") has entered into a supply agreement with 9869247 Canada Limited ("Stevens Green") dated

LOS ANGELES, July 15, 2019 /PRNewswire/ -- Mahmee (mahmee.com), a data-driven maternal and infant health tech company building the missing digital infrastructure to connect the maternal health industry and prevent critical gaps in care, announced today a $3M investment from Mark Cuban, S

CAMBRIDGE, Mass., July 15, 2019 /PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company advancing the field of targeted protein degradation to create breakthrough therapies for previously untreatable diseases, today announced key leadership transitions. Kymera Co-founder and CSO Nello Mainolfi, PhD, has been appointed President of the company as former Pre